T2-mapping, as a quantitative and accurate measurement that can be used as a noninvasive biological marker to predict the pathological classification of rectal cancer, may be beneficial to making an individualized treatment strategy before operation of rectal cancer.
This abstract and the presentation materials are available to members only; a login is required.